Guoxian Qi

1.3k total citations
75 papers, 962 citations indexed

About

Guoxian Qi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Guoxian Qi has authored 75 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 21 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Guoxian Qi's work include Acute Myocardial Infarction Research (15 papers), Coronary Interventions and Diagnostics (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). Guoxian Qi is often cited by papers focused on Acute Myocardial Infarction Research (15 papers), Coronary Interventions and Diagnostics (7 papers) and Antiplatelet Therapy and Cardiovascular Diseases (7 papers). Guoxian Qi collaborates with scholars based in China, United States and India. Guoxian Qi's co-authors include Shijie Zhao, Liye Shi, Xueyuan Li, Yang Zhang, Guang Sun, Yuan Gao, Wen Tian, Qianqian Wu, Rongwei Zhang and Jun Wang and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Scientific Reports.

In The Last Decade

Guoxian Qi

72 papers receiving 951 citations

Peers

Guoxian Qi
Rohit Khurana United Kingdom
Zaixin Yu China
Tieqiang Zhao United States
Guoxian Qi
Citations per year, relative to Guoxian Qi Guoxian Qi (= 1×) peers Tiebing Zhu

Countries citing papers authored by Guoxian Qi

Since Specialization
Citations

This map shows the geographic impact of Guoxian Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxian Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxian Qi more than expected).

Fields of papers citing papers by Guoxian Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoxian Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxian Qi. The network helps show where Guoxian Qi may publish in the future.

Co-authorship network of co-authors of Guoxian Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Guoxian Qi. A scholar is included among the top collaborators of Guoxian Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoxian Qi. Guoxian Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Qi, Guoxian, et al.. (2022). Sacubitril Valsartan Enhances Cardiac Function and Alleviates Myocardial Infarction in Rats through a SUV39H1/SPP1 Axis. Oxidative Medicine and Cellular Longevity. 2022(1). 5009289–5009289. 5 indexed citations
3.
Sun, Yujiao, Jinyang Li, Ling Chen, et al.. (2021). Relationships of Thyroid Hormones in the Normal Range to Coronary Artery Disease in Different Age Groups. International journal of gerontology. 15(3). 272–277. 1 indexed citations
4.
Sun, Guang, et al.. (2021). Circular RNA Foxo3 Relieves Myocardial Ischemia/Reperfusion Injury by Suppressing Autophagy via Inhibiting HMGB1 by Repressing KAT7 in Myocardial Infarction. Journal of Inflammation Research. Volume 14. 6397–6407. 39 indexed citations
5.
Shi, Liye, Ling Chen, Guoxian Qi, Wen Tian, & Shijie Zhao. (2019). Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials. American Journal of Cardiovascular Drugs. 20(2). 191–198. 6 indexed citations
6.
Wu, Changhao, et al.. (2018). PARP-1 Involvement in Autophagy and Their Roles in Apoptosis of Vascular Smooth Muscle Cells under Oxidative Stress. Folia Biologica. 64(3). 103–111. 20 indexed citations
7.
Wu, Qianqian, Tao Fang, Min Chen, & Guoxian Qi. (2017). Endothelial growth medium suppresses apoptosis of mesenchymal stem cells in vitro via decrease of miR-29a. Molecular Medicine Reports. 16(3). 2675–2681. 4 indexed citations
10.
Xin, Yanguo, Yuze Li, Liang Guo, et al.. (2016). Efficacy and safety of ticagrelor versus clopidogrel with different dosage in high-risk patients with acute coronary syndrome. International Journal of Cardiology. 228. 275–279. 18 indexed citations
13.
Zhang, Bo, Wei Zhang, Rongchong Huang, et al.. (2014). Gender and Age Differences Associated With Prehospital Delay in Chinese Patients Presenting With ST-Elevation Myocardial Infarction. The Journal of Cardiovascular Nursing. 31(2). 142–150. 15 indexed citations
15.
Li, Nannan, et al.. (2012). Evaluation of left ventricular diastolic function in patients with chronic heart failure. 35(22). 17–21.
16.
Liang, Meng, Zixin Zhang, Ke Xu, & Guoxian Qi. (2012). HIV-1 gp120 induces autophagy in cardiomyocytes via the NMDA receptor. International Journal of Cardiology. 167(6). 2517–2523. 12 indexed citations
18.
Sun, Yujiao, Yuze Li, Daming Jiang, et al.. (2012). Relationship between low‐density lipoprotein levels on admission and 1‐year outcome in patients with acute ST‐segment‐elevation myocardial infarction. The Kaohsiung Journal of Medical Sciences. 29(4). 206–213. 5 indexed citations
19.
Qi, Guoxian. (2008). Efficacy of Levosimendan in Congestive Heart Failure. 1 indexed citations
20.
Wei, Yidong, Kai Tang, Yanqing Chen, et al.. (2007). Multi-link Vision and MiniVision stent registry in Asian patients with coronary artery disease: a prospective, multi-center study. Chinese Medical Journal. 120(12). 1093–1096. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026